Bindslev L
Department of Anesthesiology and Intensive Care, Karolinska Hospital, Stockholm, Sweden.
ASAIO Trans. 1988 Oct-Dec;34(4):1009-13.
To avoid the drawbacks of systemic anticoagulation during prolonged extracorporeal lung assist, a heparinization technique has been developed by which partially degraded heparin is covalently end-point attached to the surface of the equipment that constitutes the extracorporeal circuit (Carmeda Bio-Active Surface; CABS). Four patients have been treated with extracorporeal carbon dioxide elimination and low pressure-low frequency ventilation for acute respiratory failure (ARF) by means of extracorporeal equipment coated with the CBAS. The author's experience is that by using the CBAS technique it is possible to perform an extracorporeal circulation on a prolonged basis with minimal systemically administered heparin, thus avoiding the risk of major coagulation defects.
为避免长时间体外肺辅助期间全身抗凝的缺点,已开发出一种肝素化技术,通过该技术将部分降解的肝素共价末端连接到构成体外循环的设备表面(卡美达生物活性表面;CABS)。四名患者因急性呼吸衰竭(ARF)接受了体外二氧化碳清除和低压低频通气治疗,使用的是涂有CBAS的体外设备。作者的经验是,通过使用CBAS技术,可以在全身肝素用量最少的情况下长时间进行体外循环,从而避免严重凝血缺陷的风险。